FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.22-SNAPSHOT  |  FHIR Version n/a  User: [n/a]

373344003: Pyridostigmine (substance)


Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jul 2002. Module: SNOMED CT core

Descriptions:

Id Description Lang Type Status Case? Module
1198642012 Pyridostigmine (substance) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core
1211830015 Pyridostigmine en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
1860111000195116 piridostigmina it Synonym (core metadata concept) Active Entire term case sensitive (core metadata concept) SNOMED CT Switzerland NRC maintained Module
836771000172110 pyridostigmine fr Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT Switzerland NRC maintained Module


0 descendants.

Expanded Value Set


Outbound Relationships Type Target Active Characteristic Refinability Group Values
Pyridostigmine (substance) Is a Reversible anticholinesterase true Inferred relationship Some
Pyridostigmine (substance) This attribute specifies the behavior that a substance will exhibit or participate in, given the appropriate context. Acetylcholine receptor agonist (disposition) false Inferred relationship Some
Pyridostigmine (substance) This attribute specifies the behavior that a substance will exhibit or participate in, given the appropriate context. Cholinesterase inhibitor false Inferred relationship Some
Pyridostigmine (substance) This attribute specifies the behavior that a substance will exhibit or participate in, given the appropriate context. Reversible anticholinesterase true Inferred relationship Some

Inbound Relationships Type Active Source Characteristic Refinability Group
Pyridostigmine bromide Is a False Pyridostigmine (substance) Inferred relationship Some
Pyridostigmine measurement Component True Pyridostigmine (substance) Inferred relationship Some 1
Pyridostigmine adverse reaction Causative agent (attribute) True Pyridostigmine (substance) Inferred relationship Some 1
Allergy to pyridostigmine Causative agent (attribute) False Pyridostigmine (substance) Inferred relationship Some
Product containing pyridostigmine in oral dose form (medicinal product form) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Pyridostigmine (substance) Inferred relationship Some 1
Product containing pyridostigmine in parenteral dose form (medicinal product form) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Pyridostigmine (substance) Inferred relationship Some 1
Pyridostigmine m/r tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Pyridostigmine (substance) Inferred relationship Some
Product containing pyridostigmine (medicinal product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Pyridostigmine (substance) Inferred relationship Some 1
Pyridostigmine bromide 5mg/mL injection solution 5mL vial The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Pyridostigmine (substance) Inferred relationship Some
Pyridostigmine bromide 5mg/mL injection solution 2mL vial The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Pyridostigmine (substance) Inferred relationship Some
Product containing precisely pyridostigmine 30 milligram/1 each conventional release oral tablet (clinical drug) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Pyridostigmine (substance) Inferred relationship Some
Allergy to pyridostigmine Causative agent (attribute) True Pyridostigmine (substance) Inferred relationship Some 1
Product containing precisely pyridostigmine 30 milligram/1 each conventional release oral tablet (clinical drug) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Pyridostigmine (substance) Inferred relationship Some 1
Product containing precisely pyridostigmine 30 milligram/1 each conventional release oral tablet (clinical drug) This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. True Pyridostigmine (substance) Inferred relationship Some 1
Pyridostigmine bromide This attribute indicates that the concept is a structural modification of another concept, and that the substance's intrinsic physicochemical properties remain unchanged. True Pyridostigmine (substance) Inferred relationship Some
Product containing precisely pyridostigmine 30 milligram/1 each conventional release oral tablet (clinical drug) The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). True Pyridostigmine (substance) Inferred relationship Some 1
Product containing only pyridostigmine (medicinal product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Pyridostigmine (substance) Inferred relationship Some 1
Pyridostigmine only product in oral dose form The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Pyridostigmine (substance) Inferred relationship Some 1
Product containing only pyridostigmine in parenteral dose form (medicinal product form) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Pyridostigmine (substance) Inferred relationship Some 1

This concept is not in any reference sets

Back to Start